2008 | 2007
June 17, 2008
Families of Spinal Muscular Atrophy and Paratek Pharmaceuticals Extend and Expand Drug Discovery Collaboration for Spinal Muscular Atrophy
June 17, 2008
ARYx Therapeutics Inc Commences Phase2/3 Clinical Trial on Oral Anticoagulant Agent ATI-5923 – EmbraceAC Comparative Study Against Leading Anticoagulant Warfarin
June 12, 2008
Idenix Announces Positive Phase I/II Data of IDX899 Confirm Potent Antiviral Activity and Favorable Safety Profile in Treatment-Naïve HIV-Infected Patients
May 16, 2008
Phenomix Announces PHX1149 Phase2b Clinical Trial Results for Type 2 Diabetes
May 7, 2008
Albireo Announces Second Closing of Series A Financing
April 16, 2008
Paratek Pharmaceuticals Completes $40 Million Private Placement to Finance Clinical Programs Including Oral Antibiotic to Combat MRSA and Other Infections
March 31, 2008
ACADIA Pharmaceuticals Initiates Second Phase III Trial with Pimavanserin in Patients with Parkinson's Disease Psychosis
March 24, 2008
Nomura Phase4 Ventures' Feature in BioCentury: Clear route to Phase IIb
February 14, 2008
Nomura Phase4 Ventures leads spin out of Albireo from AstraZeneca, raising up to US$40 in Series A equity financing
February 6, 2008
IDX899 Demonstrates Rapid and Profound Inhibition of HIV Replication in a PhaseI/II Clinical Trial in Treatment Naive HIV-Infected Patients
January 25, 2008
Phenomix Files Registration Statement For Proposed Initial Public Offering
January 16, 2008
Cerimon Pharmaceuticals Initiates Phase II/III Clinical Studies to Evaluate Its Diclofenac Patch for Mild to Moderate Pain
January 7, 2008
Idenix Pharmaceuticals Provides Update on Hepatitis C Pipeline
December 19, 2007
Altus Pharmaceuticals Reacquires ALTU-238 Global Development and Commercialization Rights
December 13, 2007
Chroma Announces Positive Phase I Efficacy Data for Novel Cancer Therapy CHR-2797
December 3, 2007
Targacept Announces Results of Phase II Study of TC-2696 in Postoperative Dental Pain
November 15, 2007
PerkinElmer Completes Acquisition of Viacell
November 15, 2007
Zosano Pharma Announces Funding Close Totaling $90 Million
November 7, 2007
ARYx Therapeutics Announces Pricing of its Initial Public Offering
November 5, 2007
Targacept to Receive $2 Million from AstraZeneca for Option to Lead Product Candidate in Alpha7 NNR Program
October 25, 2007
Paratek Pharmaceuticals Announces the Close of $40 Million Private Placement to Finance Programs to Combat MRSA Infections
October 8, 2007
OmniSonics Announces that FDA Clears OmniWave endovascular system for clot removal in peripheral vessels
October 1, 2007
PerkinElmer to Expand Genetic Screening Business Through Acquisition of ViaCell
September 28, 2007
Idenix Pharmaceuticals Restructures to Concentrate Efforts on HCV and HIV Programs
September 27, 2007
Macroflux Announces Name Change to Zosano Pharma, Inc.
September 20, 2007
Viacell Announces that Children Can be Cured of Sickle Cell Disease and Thalassemia After Sibling Cord Blood Transplantation
September 18, 2007
ViaCell Announces Expansion of ViaCord Processing Laboratory
September 4, 2007
ViaCell Announces ViaCyte Collaboration with EMD Serono, Inc.
August 30, 2007
ARYx Therapeutics Files Registration Statement for Initial Public Offering
August 14, 2007
Nabriva Announces the Initiation of Clinical Phase1 Study for Topical Antibiotic.
August 14, 2007
Altus Pharmaceuticals' ALTU-237 Enters Phase I Clinical Trial for the Treatment of Hyperoxalurias and the Potential Prevention of Kidney Stone Formation.
July 27, 2007
Targacept and GlaxoSmithKline Form Alliance in Therapeutics for CNS-related Disorders.
July 16, 2007
ACADIA Pharmaceuticals Earns Milestone on Advancement of Glaucoma Drug Candidate.
July 13, 2007
Idenix's Valopicitabine Development Program Placed on Clinical Hold in the United States.
July 9, 2007
Paratek Pharmaceuticals and Warner Chilcott Sign Collaboration Agreement for Novel, Narrow-Spectrum Agents for Acne and Rosacea.
March 8, 2007
Nomura Phase4 Ventures leads a US$55 million Series C equity financing of Phenomix Corporation.
